BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16341013)

  • 1. Morphine reward in dopamine-deficient mice.
    Hnasko TS; Sotak BN; Palmiter RD
    Nature; 2005 Dec; 438(7069):854-7. PubMed ID: 16341013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice.
    Engel JA; Nylander I; Jerlhag E
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2364-71. PubMed ID: 26508707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Gβγ-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward.
    Hoot MR; Sypek EI; Reilley KJ; Carey AN; Bidlack JM; McLaughlin JP
    Behav Pharmacol; 2013 Apr; 24(2):144-52. PubMed ID: 23412114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice.
    Mika J; Wawrzczak-Bargiela A; Osikowicz M; Makuch W; Przewlocka B
    Brain Behav Immun; 2009 Jan; 23(1):75-84. PubMed ID: 18684397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice.
    Kambur O; Männistö PT; Viljakka K; Reenilä I; Lemberg K; Kontinen VK; Karayiorgou M; Gogos JA; Kalso E
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):367-73. PubMed ID: 18834357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic mechanisms of opiate actions in brain.
    Eidelberg E; Erspamer R
    J Pharmacol Exp Ther; 1975 Jan; 192(1):50-7. PubMed ID: 164529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of pleiotrophin leads to disruption of spinal nociceptive transmission: evidence for pleiotrophin modulation of morphine-induced analgesia.
    Gramage E; Herradon G
    Eur J Pharmacol; 2010 Nov; 647(1-3):97-102. PubMed ID: 20826137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice.
    Walters CL; Godfrey M; Li X; Blendy JA
    Brain Res; 2005 Jan; 1032(1-2):193-9. PubMed ID: 15680959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of morphine-induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice.
    Murphy NP; Lam HA; Maidment NT
    J Neurochem; 2001 Nov; 79(3):626-35. PubMed ID: 11701766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration.
    Li T; Hou Y; Yan CX; Chen T; Zhao Y; Li SB
    Neurosci Lett; 2010 Nov; 485(3):256-60. PubMed ID: 20849922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased analgesic tolerance to acute morphine in fosB knock-out mice: a gender study.
    Solecki W; Krowka T; Kubik J; Kaczmarek L; Przewlocki R
    Pharmacol Biochem Behav; 2008 Oct; 90(4):512-6. PubMed ID: 18474394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals.
    Mori T; Shibasaki M; Abe M; Udagawa Y; Suzuki T
    Synapse; 2012 Nov; 66(11):931-7. PubMed ID: 22807156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
    Williams J; Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High doses of processed Aconiti tuber inhibit the acute but potentiate the chronic antinociception of morphine.
    Shu H; Hayashida M; Arita H; Huang W; Xiao L; Chiba S; Sekiyama H; Hanaoka K
    J Ethnopharmacol; 2008 Sep; 119(2):276-83. PubMed ID: 18687394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.
    Carrigan KA; Dykstra LA
    Psychopharmacology (Berl); 2007 May; 191(4):985-93. PubMed ID: 17211651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
    Kotlinska J; Pachuta A; Dylag T; Silberring J
    Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
    J Pharmacol Exp Ther; 1996 Oct; 279(1):177-85. PubMed ID: 8858991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kin interaction enhances morphine analgesia in male mice.
    D'Amato FR
    Behav Pharmacol; 1998 Jul; 9(4):369-73. PubMed ID: 10065926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.